All patients deserve access to the right testing & treatment at the right time

From Testing to Targeted Treatment Program (FT3) is a non-profit multi-stakeholder collaborative program that aims to unify, accelerate and build on existing efforts to make precision medicine a reality for all patients who could benefit from it. Co-led by patients, FT3 is strongly focused on patient needs and experiences.

All patients deserve access to the right testing & treatment at the right time

From Testing to Targeted Treatment Program (FT3) is a collaborative program to make precision medicine a reality for all patients who could benefit from it.

Program highlights

Could genetic testing unlock treatments for Cancer of Unknown Primary?

World CUP Week: Researchers are screening hundreds of tumour genes in search of drug targets that could open the door to more personalised cancer care

Find out more

Program update – September 2021

Here is an update on latest developments in FT3 including ideas to get involved and engage your network.

Find out more

2020 From Testing to Targeted Treatment Annual Report

Moving from incubation to a shared operational program

Read the full report here

Follow

From Testing to Targeted Treatments (FT3)@FT3Program·

We are thrilled that Dr Charles Steward (@Congenica) has joined the @FT3Program community as a working group ... co-lead. Together we'll be working towards demonstrating the benefits of #precisionmedicine on patient outcomes. Want to join us? http://ow.ly/kSps30s1S5p

Twitter 1463887991177371656

Lung Cancer Europe @LungCancerEu·

Join us on all socials on November 30th, 10:00 CET for the live launch of LuCE's 6th report on lung cancer: ... "Experiences and quality of life of people impacted by lung cancer in Europe", with MEP Tomislav Sokol. #LungCancer #EUBeatingCancer #EUCancerPlan #ManyFacesOneVoice

Twitter 1462804077557989385

ECPC @cancereu·

📌In many EU countries diagnostic tests are not integrated into clinical practice and are not reimbursed or ... available to all people with cancer. ❗This needs to change.
👉Please support #PMAM21 and share the message
http://bit.ly/3Cu4AxE #CrackingTheCancerCode

Twitter 1460606504055283713

About us

Our motivation

All patients deserve access to the right testing & treatment at the right time. While Precision Medicine (PM) can transform lives, its potential benefits have not yet been fully realized.

Our ambition

Our goal is to improve access to precision medicine for all patients who could benefit from it, by generating better evidence, creating awareness and building the conditions for better access, starting with testing and cancer.

Find out more

The partnership

We are an independent, nonprofit, global and multistakeholder consortium, building solutions with patients, for patients. Its members and community include individual patients, patient organizations, pharmaceutical & diagnostics companies, healthcare professionals and medical societies, payers, HTA bodies and regulators.

Find out more

Keep up to date with developments from the precision medicine ecosystem

We don’t spam. Just key info at the right time.

Founding members

Join the partnership